A screen of 350 combination therapies with 177Lu-DOTATATE reveal distinct differences to EBRT and novel action of CDK4/6 inhibitors (2020)
Attributed to:
PET imaging of PARP using 18F-olaparib
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 61
Parent Publication: JOURNAL OF NUCLEAR MEDICINE
ISSN: 0161-5505